Skip to main content
Sinocare Inc. logo

Sinocare Inc. — Investor Relations & Filings

Ticker · 300298 ISIN · CNE100001CJ0 LEI · 3003008DEKI00A51LU77 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,252 across all filing types
Latest filing 2016-04-07 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300298

About Sinocare Inc.

https://www.sinocare.com

Sinocare Inc. specializes in the research, development, and manufacturing of biosensor technology and rapid testing products for chronic disease management. The company is primarily recognized for its blood glucose monitoring systems, including meters and test strips, which serve a global patient base. Its product portfolio extends to point-of-care testing (POCT) solutions for HbA1c, uric acid, blood lipids, and other metabolic indicators. Through the integration of advanced sensing technologies and digital health platforms, Sinocare provides comprehensive diagnostic tools for diabetes and related metabolic disorders. The company focuses on delivering affordable and accurate monitoring solutions to improve the quality of life for individuals with chronic conditions worldwide.

Recent filings

Filing Released Lang Actions
关于完成工商变更登记的公告
Regulatory Filings Classification · 95% confidence The document is titled '关于完成工商变更登记的公告' which translates to 'Announcement on Completion of Industrial and Commercial Change Registration'. It details the completion of a registration change related to the company's registered capital and business license information. The text includes specifics about the change in registered capital and the issuance of a new business license by the local administration. There is no financial data, no discussion of financial results, no management commentary, no voting results, or any other report content. The document is an official announcement about a corporate registration update, which fits the category of a Regulatory Filing (RNS) as it is a general regulatory announcement that does not fit into more specific categories like capital changes (SHA) or management changes (MANG). The document length is short (1066 characters), and it is an announcement rather than a full report or detailed filing. Therefore, the best classification is Regulatory Filings (RNS).
2016-04-07 Chinese
重大资产重组进展公告
Capital/Financing Update Classification · 95% confidence The document is titled '重大资产重组进展公告' which translates to 'Major Asset Restructuring Progress Announcement'. It discusses the company's stock suspension due to planning a major asset restructuring, ongoing due diligence, and the intention to disclose a restructuring plan or report by a future date. The document is short (752 characters) and serves as an update on the progress of a major asset restructuring, not the actual restructuring plan or report itself. This fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes such as major asset restructurings. It is not a full report or final announcement but a progress update.
2016-04-01 Chinese
重大资产重组进展公告
Capital/Financing Update Classification · 95% confidence The document is titled '重大资产重组进展公告' which translates to 'Announcement on Progress of Major Asset Restructuring'. It mentions the company stock suspension due to planning a major asset restructuring and states that the company will publish progress updates every five trading days. The document is an announcement about the progress of a major asset restructuring, not the actual restructuring report or financial statements. It is relatively short (738 characters) and serves as a regulatory announcement to inform investors about the status of the restructuring process. Therefore, it fits best under the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes such as major asset restructurings.
2016-03-25 Chinese
董事会关于重大资产重组停牌公告
Regulatory Filings Classification · 95% confidence The document is titled '关于重大资产重组停牌公告' which translates to 'Announcement of Suspension of Trading Due to Major Asset Restructuring'. It details the company's plan for a significant asset reorganization involving share issuance and acquisition of a subsidiary. The document explains the reasons for the trading suspension, the timeline for disclosure, and the company's commitments regarding the asset restructuring process. It does not contain financial statements or detailed financial data but is an official announcement related to the trading suspension due to a major asset restructuring. The document length is 1766 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document is best classified as a Regulatory Filing (RNS) because it is a regulatory announcement about the suspension of trading related to a major asset restructuring, not the restructuring report itself or a financing update.
2016-03-18 Chinese
关于完成工商变更登记的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the completion of a business registration change (工商变更登记) for the company 三诺生物传感股份有限公司. It mentions the approval of amendments to the company's articles of association at the 2015 annual general meeting and the subsequent filing and approval of these changes with the local industrial and commercial administration bureau. The document does not contain financial statements, audit information, or detailed management discussion. It is a regulatory announcement about corporate registration updates rather than a full report or financial disclosure. The document length is short (849 characters), and it serves as a formal notice of the completion of a corporate registration change. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2016-03-11 Chinese
中信证券股份有限公司关于公司2015年度持续督导跟踪报告（修订稿）
Audit Report / Information Classification · 95% confidence The document is titled as a "2015年度持续督导跟踪报告(修订稿)" which translates to "2015 Annual Continuous Supervision Follow-up Report (Revised)" issued by 中信证券股份有限公司 (CITIC Securities Co., Ltd.) regarding 三诺生物传感股份有限公司 (Sinocare Inc.). The content includes detailed supervision activities, review of company disclosures, governance, fundraising supervision, internal controls, and regulatory compliance issues during 2015. It also lists regulatory measures and corrective actions taken by the sponsor institution. The document is a detailed report on the sponsor's ongoing supervision and monitoring of the company, which is typical of a continuous supervision or audit-related report rather than a full annual report or earnings release. It contains substantive content about regulatory compliance, internal controls, and sponsor opinions, which aligns with an Audit Report / Information filing rather than a simple announcement or a general regulatory filing. The length (6185 characters) and detailed content confirm it is a full report, not just an announcement. Therefore, the most appropriate classification is Audit Report / Information (AR). FY 2015
2016-03-09 Chinese

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.